Transcript:
Pulmonology Today: How might tirzepatide’s dual incretin mechanism contribute to reductions in cardiovascular and kidney events beyond its weight-loss effects in patients with obstructive sleep apnea (OSA)?
Dr. Anne Marie Morse: One…

Transcript:
Pulmonology Today: How might tirzepatide’s dual incretin mechanism contribute to reductions in cardiovascular and kidney events beyond its weight-loss effects in patients with obstructive sleep apnea (OSA)?
Dr. Anne Marie Morse: One…